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Microcephaly 
Background 
1. Definition varies  
o Head circumference [occipito-frontal circumference (OFC)]  
 <2 standard deviations (SD) below mean for age (<3rd percentile)  
 <3 SD (<1st percentile) = severe microcephaly
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o Actual growth charts  
 http://www.cdc.gov/growthcharts/charts.htm#set1  
o Some definitions adjust for prematurity and parental head size 
2. General information  
o May require serial measurements (crossing several percentile lines); in utero 
antenatal diagnosis requires multiple measures less than 3 or 4 SD  
3. CDC growth charts based on US population are slightly different than WHO charts  
o http://www.who.int/childgrowth/standards/hc_for_age/en/index.html  
 
Pathophysiology 
1. Pathology of disease  
o Lack of brain development from variety of causes or insult to a previously 
normal brain 
2. Incidence, prevalence  
o By definition 1-3% of population; individual etiologies much less common 
3. Risk factors / etiology  
o Genetic  
 Isolated vs. syndromic microcephaly  
 Several genes and multiple syndromes with associated 
anomalies 
 Microcephalia vera (MV) and microcephaly with simplified gyral 
pattern (MSG) are genetic forms of isolated congenital 
microcephaly with no extracerebral malformation 
 Well-known associated genetic syndromes  
 Down syndrome, Trisomy 18, Trisomy 13, Cri-du-chat  
o Neuroanatomic abnormalities  
 Neural tube defects, holoprosencephaly, others 
 See http://www.merck.com/mmpe/sec19/ch292/ch292b.html#sec19-
ch292-ch292b-2567 
o Metabolic  
 Aminoacidurias, urea cycle disorders, organic acidurias, storage dz 
o Infection  
 TORCH  
 Toxoplasmosis 
 Hepatitis B 
 Syphilis 
 Herpes zoster 
 Rubella 
 Cytomegalovirus (CMV) 
 Herpes simplex virus 
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o Drug / toxin exposure in utero  
 Fetal alcohol syndrome, maternal opioid use 
o Acquired brain injury  
 Hypoxic-ischemic insult, intraventricular hemorrhage 
o Systemic disease  
 Renal failure, biliary atresia, etc 
o Severe malnutrition 
o Hyperthermia  
 Associated with significant fever in 1st trimester with seizures and 
facial anomalies 
o Abnormal fusion of cranial sutures  
 Craniosynostosis 
4. Morbidity / mortality  
o Most cases associated with some degree of mental retardation 
o Severity correlates with degree of microcephaly  
o Craniosynostosis morbidity depends on severity and if treated early 
(referred by 8-12 months)  
o Most conditions  
 Prognosis depends on cause, severity, and associated abnormalities 
 
Diagnosis 
1. History  
o Prenatal history  
 Maternal medical illness, medications, tobacco, substance abuse 
 Findings on prenatal lab tests and ultrasounds 
o Birth history  
 Infections, medications, complications 
o Family history  
 Similar conditions, consanguinity, syndromes 
 Parental head size 
o Developmental and neurologic history  
 Milestones, seizures 
2. Physical examination  
o Technique of measurement  
 http://www.simulconsult.com/resources/ftemp20.html 
o Compare height, weight, OFC percentiles 
o Genetic influences  
 Weaver curve compares child's OFC to that expected based on 
parental OFC
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o OFC trajectory; height and weight trajectories 
o General appearance  
 Dysmorphic features 
o Head  
 Sutures and fontanelles 
 Head symmetry 
o Eyes  
 Chorioretinitis, cataracts 
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o Mouth  
 Midline defects with holoprosencephaly and related conditions 
o Skin  
 Petechiae, jaundice, eczema (infection, metabolic or systemic dz) 
o Abdomen  
 Hepatosplenomegaly with infection, metabolic dz 
o Neurologic  
 Reflexes, symmetry, muscle tone 
3. Diagnostic testing  
o Physical findings can be used to identify syndromes, for example entering 
findings into OMIM database  
 http://www.ncbi.nlm.nih.gov/omim/  
o Especially if dysmorphic features, short stature  
 Consider karyotype, genetic analysis 
o Maternal serum phenylalanine level 
o Fasting plasma and urine amino acids 
o Serum ammonia 
o Thyroid stimulating hormone 
o Infection  
 TORCH titers 
 Urine CMV culture 
 Maternal and infant HIV 
o Diagnostic imaging  
 MRI esp if abnormal development or neuro exam 
 CT or cephalometric radiography if craniosynostosis suspected 
4. Diagnostic criteria  
o OFC  
 <2 SD from mean for age 
 <3 SD severe; or  
 Decreasing head growth, crossing 2 or 3 major percentile lines on 
growth curve 
5. Recommendations  
o Neuroimaging is recommended in a child with global developmental delay  
 As presence of physical findings (e.g., microcephaly, focal motor 
findings) increases, the yield of making a specific diagnosis 
increases, and scan has higher yield
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o Every child (birth through 24 months of age) found to have microcephaly 
should be followed and periodically screened for late-onset congenital or 
acquired hearing loss
4
  
 
Differential Diagnosis 
1. Key DDx  
o Craniosynostosis  
2. Extensive DDx  
o Primary  
 Genetic  
 Isolated Microcephaly: present at birth, no other anomalies  
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o Receding forehead, normal-sized face, and relatively 
large-appearing ears 
 Autosomal dominant: normal stature, normal intelligence or 
mild MR  
 X-Linked: severe MR  
 Syndromic  
 Trisomy 13 
 Trisomy 18 syndrome  
 Cornelia de Lange's syndrome  
 Rubinstein-Taybi syndrome  
 Prader-Willi syndrome 
 Neuroanatomic  
 Neural tube defects  
 Holoprosencephaly  
o Incomplete development and septation of midline 
CNS structures 
 Varying degrees of brain separation, hypotelorism, facial 
clefts, and nasal malformations 
 Atelencephaly  
o Absence of cerebrum and associated structures 
 Lissencephaly  
o Surface of the brain appears completely or partially 
smooth with loss or reduction of sulci 
 Schizencephaly  
o Asymmetric infolding of cortical gray matter  
 Polymicrogyria  
o Excessive gyri on surface of brain  
 Macrogyria  
o Reduction in number of sulci of cerebrum and is 
often seen in lissencephaly  
 Fetal brain disruption sequence  
o Severe microcephaly of prenatal onset (average OFC 
5.8 SD below the mean), overlapping cranial sutures, 
prominence of the occipital bone, and scalp rugae 
o Secondary  
 Metabolic disorders  
 PKU  
o Part of Newborn screen in all 50 states, District of 
Columbia, Puerto Rico, US Virgin Islands and Guam 
 Methylmalonic aciduria  
o Typically have severe metabolic acidosis with an 
increased anion gap, ketosis, and hyperammonemia 
 Citrullinemia  
o Quantitative plasma amino acid analysis 
 Environmental factors  
 TORCH infections: Toxoplasmosis, Other (syphilis), 
Rubella, CMV, HSV 
 In utero toxin exposure (ie ETOH, illicits, solvents) 
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 Hypoxic-ischemic insults 
 Intraventricular hemorrhage or stroke 
 Malnutrition 
 
Therapeutics 
1. Acute treatment  
o Not an urgent condition unless associated metabolic or systemic illness 
present 
2. Further management  
o If severe and congenital, evaluation and consultation indicated 
o If OFC is low-normal, can be followed serially 
o Management depends on etiology  
 Craniosynostosis  
 Referral to craniofacial team by age 8-12 months 
 Dietary modification for certain metabolic syndromes 
 Treatment if specific infection identified 
 Treat underlying medical illness, as appropriate (thyroid, renal, 
hepatic) 
 Neurosurgical referral for neural tube defects, neuroanatomic 
anomalies 
 Genetics, developmental pediatrics referral if genetic syndrome 
identified 
3. Long-term care  
o Family and patient typically need long term psychological support 
o Medical social work involvement for support and resources
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Follow-Up 
1. Return to office  
o Newborn  
 Depends on etiology and severity 
o Declining OFC in older child: repeat exam in 1-2 months if 
developmentally normal 
o Recommendations for earlier follow-up  
 Vomiting, delayed milestones, focal neurologic symptoms 
2. Refer to specialist  
o Newborn  
 Genetics, developmental pediatrics, neurosurgery as indicated 
o Older child  
 Depends on suspected cause, consider developmental pediatrics 
o Craniosynostosis  
 Craniofacial team (neurosurgery, plastic surgery, otolaryngology, 
speech therapy, audiology, radiology, orthodontics, etc.) 
3. Admit to hospital  
o Concern regarding increased intracranial pressure (vomiting, altered 
awareness) 
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Prognosis 
1. Poor postnatal head growth in preterm infants becomes more evident by 2 years 
and is strongly associated with poor neurodevelopmental outcome and cerebral 
palsy
6
  
2. Otherwise prognosis depends on underlying cause 
 
Prevention  
1. Women who use heroin should be maintained on an opioid agonist other than 
heroin during pregnancy; use of long-acting morphine is superior to methadone in 
abstention rates during pregnancy
7
  
2. Identify women who use alcohol in pregnancy and counsel regarding cessation8  
3. Ensure needed immunizations in women prenatally 
 
Patient Education 
1. National Institute of Neurological Disorders and Stroke  
o http://www.ninds.nih.gov/disorders/microcephaly/microcephaly.htm 
2. National Library of Medicine: Medline Plus  
o http://www.nlm.nih.gov/medlineplus/ency/article/003272.htm 
3. Foundation for Children with Microcephaly  
o http://www.childrenwithmicro.org/ 
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